Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17 ‐10 CIARA trial)

British Journal of Haematology,Volume 183, Issue 2, Page 235-241, October 2018.

https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15546?af=R

Source: British Journal of Haematology - October 31, 2018 Category: Hematology Authors: J ürgen Krauter, Walter Fiedler, Richard F. Schlenk, Peter Paschka, Felicitas Thol, Michael Lübbert, Mohammed Wattad, Mareike Verbeek, Christian Könecke, Barbara Neuhaus, Armin Papkalla, Maxim Kebenko, Melanie Janning, Konstanze Döhner, Source Type: research